Track the Fresh Tracks Therapeutics, Inc. share price and the full insider trade history of the company, a listed issuer based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was filed on 11 June 2024 (Acquisition). Among the most active insiders: Exploration Capital, LLC. Every trade is accessible without an account.
24
Insider Decl.
n/a
Thresholds
€709,911
19 ops.
Buy Volume
€91
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Fresh Tracks Therapeutics, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
31Σ signal
Buys €709,911€91 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Fresh Tracks Therapeutics, Inc. es una empresa centrada en el desarrollo de tratamientos innovadores para trastornos psiquiátricos. Cotiza en el mercado XNAS.